arznei-telegramm Logo a-t Kurzlogo
    ❮ a-t 12/2019 a-t ❯
    This is a translation of the table of contents. One article of each issue is translated and freely available.
    table of contents
    SPOT ON

    Taking antihypertensives better at bedtime?

    THERAPY FROM A CRITICAL VIEWPOINT

    CAROLINA trial: dipeptidyl peptidase 4 inhibitor linagliptin compared with the sulfonylurea glimeperide

    Cannabidiol: a universal remedy?
    free

    a-t READERS QUESTIONS AND COMMENTS

    Avoid lavender oil (LASEA) in breast cancer?

    IN BRIEF

    THOMAPYRIN TENSION DUO: Sanofi ousts pharmacies

    Multiple sclerosis drug alemtuzumab (LEMTRADA): updated restrictions of use

    Adrenalin auto-injector EMERADE: activation failure after storage at “too high temperatures”

    SIDE EFFECTS

    Reduced milk flow with levonorgestrel-releasing intrauterine systems

    Risk of breakage of intrauterine devices: ANCORA and NOVAPLUS withdrawn from the French market

    e a-t ON THE INTERNET

    Cannabidiol (EPIDYOLEX) for severe epilepsy

    Chronic inflammatory bowel disease: avoid titanium dioxide?

    arznei-telegramm

    Independent drug information – in English

    Concise, critical evaluations of drugs and medical devices for evidence-based therapy and patient advice on benefits and risks – independent, ad-free and funded exclusively by subscriptions.

    Browse free articles